Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly - podcast episode cover

Dr. Jeremy Faust, Paychex CEO & Cramer’s Outlook For Eli Lilly

Dec 23, 202145 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

The Santa Claus rally continued today, with the Dow gaining 261 points, the S&P climbing 1.02%, and the NASDAQ jumping 1.18% and Jim Cramer is breaking down all the action. Next, as omicron spreads rapidly, emergency physician Dr. Jeremy Faust shares his plan that could help slow the spread. Plus, Cramer’s writing a prescription for Eli Lilly & digging into the buying opportunity the big pharma powerhouse provides. Then, what’s state of the labor market after the emergence of omicron? Cramer’s asking the head of one of the country’s biggest payroll processors, CEO of Paychex Marty Mucci. Finally, post-COVID, home is where the work is - Cramer has some stocks that could benefit from the continuing rise of the home office. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android